Dr. James Speyer, MD

  • East Patchogue, NY
  • Hematologist and oncologist
NPI1871595678
Medicare services, 2021
483
Part D claims, 2022
109
Publications
9
Clinical trials
2
Industry payments
$12
Practice address
160 E 34th St Fl 10 Fl 10, New York, NY 10016
Practice phone
Call (212) 731-6193
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

New York University - New York (160 E 34th St)

Multi-specialty group site · New York, New York

Find Dr. Speyer's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. James Speyer is a hematologist and oncologist in East Patchogue, New York

Dr. Speyer practices at New York University - New York (160 E 34th St) in New York, New York.

Dr. Speyer's NPI, 1871595678, was assigned on August 11, 2005. Dr. Speyer graduated from Johns Hopkins University School of Medicine in 1974. Dr. Speyer holds New York license 123865.

NPI and contact details
NPI enumeration date
August 11, 2005
NPI status
Active
Practice phone
(212) 731-6193
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
78
Medical school graduation
1974

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. James Speyer practices in New York and East Patchogue

Dr. Speyer's primary practice is New York University - New York (160 E 34th St), at 160 E 34th St Fl 10 Fl 10, New York, NY 10016. The practice phone is (212) 731-6193. The NPI Registry lists Dr. Speyer's practice address as 100 Hospital Rd, East Patchogue, NY 11772.

  • New York University - New York (160 E 34th St)Primary
    160 E 34th St Fl 10 Fl 10, New York, NY 10016Phone(212) 731-6193
  • NPI Registry address
    100 Hospital Rd, East Patchogue, NY 11772 · Suffolk CountyPhone(212) 731-5165

Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Practice Data

Dr. James Speyer is affiliated with 1 site of care and 1 medical group

Dr. Speyer's primary practice is New York University - New York (160 E 34th St) in New York, New York. The medical group on file is NYU Langone Orthopedic Surgery Associates.

New York University - New York (160 E 34th St)Multi-specialty group site · New York, New YorkPrimary
NYU Langone Orthopedic Surgery AssociatesPrimary care group, New York, NY

Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dmand AI tracks the EHR system at Dr. James Speyer's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Speyer practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
New York University - New York (160 E 34th St)Available with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Speyer practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. James Speyer is one of 996 hematologists and oncologists in New York

Hematology and oncology is Dr. Speyer's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Speyer is licensed in New York.

Specialties and state licenses

  • Hematology and oncology, New YorkPrimaryLicense 123865 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Speyer

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. James Speyer billed Medicare for 483 services in 2021

CMS data shows 483 Medicare services from Dr. Speyer across 3 procedure codes in 2021, all of them office visits. Medicare paid $39,481 for them. Every service was in an office.

Medicare services, 2021483
Paid by Medicare$39,481
Procedure codes3

Dr. Speyer's Medicare services by type, 2020 to 2021

  • 2020
  • 2021
Office and hospital visits
2020: 3982021: 48321%

Dr. Speyer compared with the New York median for hematologists and oncologists, 2021

  • Dr. Speyer
  • New York median
Medicare services
483vs 66828% below
Part D claims
109vs 25858% below

Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.

Dr. Speyer's most billed Medicare procedure codes, 2021

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Speyer

Need commercial claims for Dr. Speyer?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Speyer and other hematologists and oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. James Speyer's patients have a median age of 72

Across all payers, Dmand AI patient panel data puts Dr. Speyer's median patient age at 72, with 100% women.

Dr. Speyer's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women100%
  • Men0%

Source: Dmand AI Patient Panel Data

Dr. James Speyer wrote 109 Medicare Part D claims in 2022

In 2022, Dr. Speyer wrote 109 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $8,645 in total drug cost. In 2021, CMS named 515 claims across 9 drugs.

Part D claims, 2022109
Drugs named by CMS2
Total drug cost$8,645

Dr. Speyer's most prescribed drugs by claims, 2022

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2021 to 2022

  • 2021
  • 2022
Claims for drugs CMS names
2021: 5152022: 10979%

Drugs named by CMS: 2 in 2022, 9 in 2021.

See all prescribing by Dr. Speyer

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Speyer by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. James Speyer has 9 publications on record

Dmand AI links 9 papers to Dr. Speyer, published from 2012 to 2017. 2014 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Breast Neoplasms. Dr. Speyer has published most often in Breast Cancer Res. Dr. Speyer's most frequent co-authors are Yelena Novik, MD, Amy D. Tiersten, MD and Sylvia Adams, MD.

Papers9
Years published2012 to 2017

Dr. Speyer's papers by year, 2012 to 2017

Topics Dr. Speyer writes about most

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms

Dr. Speyer's most frequent co-authors

Recent publications by Dr. Speyer

See all 9 publications and co-authors

See who Dr. Speyer researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Speyer works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. James Speyer has worked on 2 clinical trials

Dmand AI links Dr. Speyer to 2 clinical trials. Conditions studied include Breast Neoplasms and Breast Diseases. NYU Langone Health sponsors the most, 2.

Clinical trials with Dr. Speyer by phase

  1. 1Early phase 1: 1 trial
  2. NonePhase 1: no trials
  3. 1Phase 1/2: 1 trial
  4. NonePhase 2: no trials
  5. NonePhase 3: no trials
  6. NonePhase 4: no trials

Conditions in Dr. Speyer's trials

  • Breast Neoplasms
  • Breast Diseases

Investigators on the most trials with Dr. Speyer

Recent clinical trials with Dr. Speyer

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. James Speyer received $12 in industry payments in 2021

CMS Open Payments shows 1 general payment to Dr. Speyer from 1 drug or device company in 2021. Education make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $12.

Companies that paid Dr. Speyer the most, 2021 to 2021

Share is of all general payments to this clinician.

See all payments to Dr. Speyer

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. James Speyer graduated from Johns Hopkins University School of Medicine

Dr. Speyer graduated from Johns Hopkins University School of Medicine in 1974.

  1. Medical schoolJohns Hopkins University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. James Speyer's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. James Speyer

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. James Speyer's NPI number?

Dr. James Speyer's NPI number is 1871595678. It was assigned on August 11, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. James Speyer?

Dr. James Speyer is a hematologist and oncologist in East Patchogue, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. James Speyer practice?

Dr. Speyer practices at 160 E 34th St Fl 10 Fl 10, New York, NY 10016. Dr. Speyer also practices at 100 Hospital Rd, East Patchogue, NY 11772. Dr. Speyer's primary practice is New York University - New York (160 E 34th St) in New York, New York.

What is Dr. James Speyer's office phone number?

The practice phone on file for Dr. Speyer is (212) 731-6193.

What is Dr. James Speyer's medical license number?

Dr. Speyer holds New York license 123865.

What medical group is Dr. James Speyer part of?

Dr. Speyer is linked to NYU Langone Orthopedic Surgery Associates.

Does Dr. James Speyer accept Medicare?

Yes. CMS data shows Dr. Speyer billed Medicare for 483 services in 2021.

What services does Dr. James Speyer bill to Medicare?

In 2021, Dr. Speyer's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and office visit, established patient (99215).

Where did Dr. James Speyer go to medical school?

Dr. Speyer graduated from Johns Hopkins University School of Medicine in 1974.

What drugs does Dr. James Speyer prescribe most?

In 2022 Medicare Part D data, Dr. Speyer's most prescribed drugs by claims were Letrozole and Exemestane.

Show 4 more questionsShow fewer questions

Has Dr. James Speyer received payments from drug or device companies?

CMS Open Payments shows $12 in general payments to Dr. Speyer from 1 company from 2021 to 2021. The largest total came from Gilead Sciences, Inc.

How long has Dr. James Speyer been practicing?

Dr. Speyer graduated from medical school in 1974, 52 years ago.

Does Dr. James Speyer do research?

Dmand AI links 9 publications to Dr. Speyer, published from 2012 to 2017. Dr. Speyer has worked on 2 clinical trials.

Who does Dr. James Speyer publish with?

Dr. Speyer's most frequent co-authors are Yelena Novik, MD (5 shared papers), Amy D. Tiersten, MD (4 shared papers) and Sylvia Adams, MD (3 shared papers).

Selling to hematology and oncology practices?

See hematologists and oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)